Join to access to all OVN content. Join for Free

Results for 'ALK'

How a Bold Yes Became a Scientific Breakthrough
Partner Avatar Monty Pal
How a Bold Yes Became a Scientific Breakthrough

City of Hope, Monty Pal, Linda Malkas, AOH1996, Ana Olivia Healy

Dr. Linda Malkas shares the story behind AOH1996—how one bold “yes” led to a new cancer drug and a legacy built from love and science.

Jun 9th • 47 mins listen

Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story
Partner Avatar Rebecca Previs
Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story

Labcorp, Rebecca Previs, Ken Schlosser, biomarker, lung cancer, ALK+, advocacy, precision

Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.

Jul 31st • 23 mins listen

The HIGH FIVE Challenge
Partner Avatar MSL Talk: Tom Caravela, Mel Robbins
The HIGH FIVE Challenge

Mel Robbins, High Five Habit, Tom Caravela, MSL Talk Podcast, High Five Challenge

In this episode, Tom Caravela delves into the transformative power of Mel Robbins' high five habit. He begins by introducing Mel Robbins and her background, then unpacks the concept and practical application of the high five habit. Tom discusses research and studies that validate its effectiven…

Oct 12th • 13 mins listen

How Medical Affairs Professionals Should Engage with Digital Opinion Leaders
Partner Avatar MSL Talk: Tom Caravela, Paul Ward
How Medical Affairs Professionals Should Engage with Digital Opinion Leaders

Digital Opinion Leaders, Medical Affairs, MSL Talk, Paul Ward, Tom Caravela, Medical Watch, AI in Medical Affairs, Digital Engagement, Online Misinformation, Scientific Credibility

In this episode of MSL Talk, Tom Caravela sits down with Paul Ward for an insightful conversation on the evolving role of Digital Opinion Leaders (DOLs) in Medical Affairs. Sponsored by Medical Watch, this episode explores why DOLs matter, how to identify the right ones, and what tools MSLs can use …

May 20th • 37 mins listen

How to Silence Self Doubt And Create Unstoppable Confidence
Partner Avatar MSL Talk: Tom Caravela, Allison Trucillo
How to Silence Self Doubt And Create Unstoppable Confidence

self-doubt, inner critic, negativity bias, positive self-talk, mindfulness habits, personal growth, building confidence, positive affirmations

In this episode, Tom Caravela welcomes Allison Trucillo to discuss the journey of overcoming self-doubt and the inner critic. Allison shares her personal experiences and provides tools and strategies to combat negativity bias and foster an inner champion. The conversation emphasizes the importance o…

Jul 22nd • 40 mins listen

MSL Talk Podcast Year in Review-Highlights to be Grateful For
Partner Avatar MSL Talk: Tom Caravela, Arthur Chan
MSL Talk Podcast Year in Review-Highlights to be Grateful For

digital marketing strategies, content optimization, search engine ranking, keyword research tools, SEO best practices

In this Thanksgiving episode, Tom Caravela is joined by Arthur Chan to explore a range of topics pertinent to MSLs and Medical Affairs professionals. Arthur shares his career journey and emphasizes the importance of diversity and emotional intelligence in the industry. The discussion covers pre…

Nov 22nd • 51 mins listen

How Engineered Antibodies and Next Generation Imaging Tools are Reshaping Cancer Care with Anna Wu, Ph.D.
Partner Avatar Monty Pal
How Engineered Antibodies and Next Generation Imaging Tools are Reshaping Cancer Care with Anna Wu, Ph.D.

City of Hope, Monty Pal, Anna Wu, engineered antibodies, PET, imaging, radioisotope, CEA directed agent, PSCA targeted radiopharmaceutical, pancreatic cancer, prostate cancer

In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Anna Wu, Ph.D., Chair of the Department of Immunology and Theranostics at City of Hope, joins host Monty Pal, M.D., for an engaging discussion on how innovations in antibody engineering and imaging are improving clinicians’…

Mar 9th • 42 mins listen

Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
Partner Avatar Jesus Izaguirre-Carbonell
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing

Quest Diagnostics, Jesus Izaguirre Carbonell, Thoman Slavin, MRD testing, minimal residual testing, precision tool, biomarker, ctDNA, circulating tumor DNA

Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.

Jul 7th • 19 mins listen

Pushing the Limits of Cancer Research and Surgery
Partner Avatar Monty Pal
Pushing the Limits of Cancer Research and Surgery

City of Hope, Monty Pal, Mustafa Raoof, PIPAC, peritoneal, pancreatic cancer, surgical oncology

Dr. Mustafa Raoof on PIPAC, pancreatic cancer research, and how global innovation can shape the next chapter of surgical oncology.

Apr 7th • 38 mins listen

Building the First AI Agent for Cancer Research
Partner Avatar Monty Pal
Building the First AI Agent for Cancer Research

City of Hope, Monty Pal, Enrique Velazquez Villarreal, Latino, colorectal cancer, mentor, genomics, AI, artificial intelligence, multiomic

Dr. Enrique Velazquez Villarreal on AI, genomics, and why young Latinos are at the heart of his work to improve colorectal cancer research and care.

May 5th • 49 mins listen

Why Genetic Testing Should Be Standard in Prostate Cancer
Partner Avatar Rebecca Previs
Why Genetic Testing Should Be Standard in Prostate Cancer

Labcorp, Rebecca Previs, Sarah Young, genetic counselor, genetic testing, prostate cancer, urologic oncology, germline, somatic, PARP inhibitors, digital

Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.

May 18th • 19 mins listen

Tumor-Agnostic Therapies and the Future of HER2 in Oncology
Partner Avatar Rebecca Previs
Tumor-Agnostic Therapies and the Future of HER2 in Oncology

Labcorp, Rebecca Previs, Heidi Ko, HER2, NGS, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker, ERBB2, IHC, FISH, biomarker

What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.

Jun 8th • 20 mins listen

Rethinking How We Track and Treat Cancer
Partner Avatar Rebecca Previs
Rethinking How We Track and Treat Cancer

Labcorp, Rebecca Previs, Michelle Green, genomics, ASCO, HER2, HER3, MRD, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, ctDNA, biomarker

HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.

Jul 13th • 19 mins listen

What are the most common behavioral-based job interview questions?
Partner Avatar Michael Pietrack
What are the most common behavioral-based job interview questions?

What are the most common behavioral-based job interview questions? Now that you know what #behavioralinterview #jobinterviews Questions sound like and how to use the #starmodel to answer them, you’re probably wondering what questions you’ll likely get. Well, today we’re goin…

Sep 10th • 4 mins listen

ASPIRING MSL INSIGHTS - What you need to know about phone etiquette
Partner Avatar Michael Pietrack
ASPIRING MSL INSIGHTS - What you need to know about phone etiquette

👉 Did you know that phone etiquette costs some aspiring MSLs their dream job? With so much stacked against you in trying to get your first MSL job, don’t allow your phone skills to be what stumbles you. In this short video we will discuss two pro tips that will ensure the call with the HM s…

Sep 26th • 3 mins listen

Aspiring MSL Insights: How to Ensure Your Questions Aren't Taken the Wrong Way
Partner Avatar Michael Pietrack
Aspiring MSL Insights: How to Ensure Your Questions Aren't Taken the Wrong Way

Aspiring MSL Insights: How to Ensure Your Questions Aren't Taken the Wrong Way The better the questions job candidate's ask during a job interview, the better hire they are perceived to be. But some questions in the interview deserve a preface before you ask it. Without a preface the question could…

Oct 10th • 4 mins listen

The Truth Behind Sign-On Bonuses – What You Need to Know
Partner Avatar Michael Pietrack
The Truth Behind Sign-On Bonuses – What You Need to Know

The Truth About Sign-On Bonuses A sign-on bonus is the biggest misnomer in all of hiring. Why? Well, think about it. Are cash sign-on bonuses just given to sweeten the pot, just to get you to sign? They may have been at one time, but in today’s world, a sign-on bonus serves a different purpos…

Nov 25th • 3 mins listen

Season 1, Episode 10: Pursuing Dreams with Michael Cox
Partner Avatar Michael Pietrack
Season 1, Episode 10: Pursuing Dreams with Michael Cox

We are thrilled to bring you Michael Cox, a leader in the pharmaceutical industry, who shares his journey and insights in this conversation. Learn about his transition from clinical operations to medical communications and the risks he took to pursue his dreams. He also talks about his experience le…

Apr 29th • 30 mins listen

Season 1, Episode 23: Revolutionizing Cancer Treatment with Paul Romness
Partner Avatar Michael Pietrack
Season 1, Episode 23: Revolutionizing Cancer Treatment with Paul Romness

Welcome back to the Pharmaverse, where we speak to the greatest voices in Pharma, to learn from their leadership and incredible careers! In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Paul Romness, CEO of OS Therapies. The conversation delves into the inspiring sto…

Nov 18th • 25 mins listen

Advancing Clinical Trial Equity
OVN Avatar Cancer Buzz Podcast
Advancing Clinical Trial Equity

Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and incl…

Jun 25th • 8 mins listen

Related Topics

Meet Our Innovation Partners

Loading partners...